Adipocyte lipin 1 is positively associated with metabolic health in humans and regulates systemic metabolism in mice — Andrew LaPoint (2023) | RDL Network
Adipocyte lipin 1 is positively associated with metabolic health in humans and regulates systemic metabolism in mice
Preprint 2023 en
Authors
AL
Andrew LaPoint
JS
Jason Singer
DF
Daniel Ferguson
Abstract
1 min read
Abstract Dysfunctional adipose tissue is believed to promote the development of hepatic steatosis and systemic insulin resistance, but many of the mechanisms involved are still unclear. Lipin 1 catalyzes the conversion of phosphatidic acid to diacylglycerol (DAG), the penultimate step of triglyceride synthesis, which is essential for lipid storage. Herein we found that adipose tissue LPIN1 expression is decreased in people with obesity compared to lean subjects and low LPIN1 expression correlated with multi-tissue insulin resistance and increased rates of hepatic de novo lipogenesis. Comprehensive metabolic and multi-omic phenotyping demonstrated that adipocyte-specific Lpin1-/- mice had a metabolically-unhealthy phenotype, including liver and skeletal muscle insulin resistance, hepatic steatosis, increased hepatic de novo lipogenesis, and transcriptomic signatures of nonalcoholic steatohepatitis that was exacerbated by high-fat diets. We conclude that adipocyte lipin 1-mediated lipid storage is vital for preserving adipose tissue and systemic metabolic health and its loss predisposes mice to nonalcoholic steatohepatitis.
Andrew LaPoint, Jason Singer, Daniel Ferguson, Trevor M. Shew, M. Katie Renkemeyer, Hector H. Palacios, Rachael L. Field, Sireeesha Yerrathota, Roshan Kumari, Mahalakshmi Shankaran, Gordon I. Smith, Jun Yoshino, Mai He, Gary J. Patti, Marc Hellerstein, Samuel Klein, E. Matthew Morris, Jonathan R. Brestoff, Brian N. Finck, Andrew J. Lutkewitte
Raquel Carvalho-Gontijo, Cuijuan Han, Lei Zhang, Vivian Zhang, Mojgan Hosseini, Kristin L. Mekeel, Bernd Schnabl, Rohit Loomba, Michael Karin, David A. Brenner, Tatiana Kisseleva
Discussion(0)
No comments yet. Be the first to comment.